☰

Vanessa M. Hubbard, Ph.D. - Publications

Affiliations: 
2011 Yeshiva University, New York, NY, United States 
Area:
Immunology, General Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Hubbard VM, Valdor R, Macian F, Cuervo AM. Selective autophagy in the maintenance of cellular homeostasis in aging organisms. Biogerontology. 13: 21-35. PMID 21461872 DOI: 10.1007/S10522-011-9331-X  0.561
2011 Lu SX, Kappel LW, Charbonneau-Allard AM, Atallah R, Holland AM, Turbide C, Hubbard VM, Rotolo JA, Smith M, Suh D, King C, Rao UK, Yim N, Bautista JL, Jenq RR, et al. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation. Plos One. 6: e21611. PMID 21760897 DOI: 10.1371/Journal.Pone.0021611  0.677
2010 Hubbard VM, Valdor R, Patel B, Singh R, Cuervo AM, Macian F. Macroautophagy regulates energy metabolism during effector T cell activation. Journal of Immunology (Baltimore, Md. : 1950). 185: 7349-57. PMID 21059894 DOI: 10.4049/Jimmunol.1000576  0.655
2010 Lu SX, Holland AM, Na IK, Terwey TH, Alpdogan O, Bautista JL, Smith OM, Suh D, King C, Kochman A, Hubbard VM, Rao UK, Yim N, Liu C, Laga AC, et al. Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 185: 1912-9. PMID 20622117 DOI: 10.4049/Jimmunol.0903148  0.553
2009 Lu S, Willis L, Charbonneau-Allard A, Atallah R, Holland A, Turbide C, Hubbard V, Rotolo J, Smith O, Suh D, King C, Rao U, Yim N, Kochman A, Bautista J, et al. Ceacam1 Regulates Experimental Graft-Versus-Host-Disease Biology of Blood and Marrow Transplantation. 15: 13. DOI: 10.1016/J.Bbmt.2008.12.038  0.61
2008 Lu SX, Alpdogan O, Lin J, Balderas R, Campos-Gonzalez R, Wang X, Gao GJ, Suh D, King C, Chow M, Smith OM, Hubbard VM, Bautista JL, Cabrera-Perez J, Zakrzewski JL, et al. STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease. Blood. 112: 5254-8. PMID 18838616 DOI: 10.1182/Blood-2008-03-147322  0.578
2008 Alpdogan SO, Lu SX, Patel N, McGoldrick S, Suh D, Budak-Alpdogan T, Smith OM, Grubin J, King C, Goldberg GL, Hubbard VM, Kochman AA, van den Brink MR. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation. Blood. 112: 4755-64. PMID 18815289 DOI: 10.1182/Blood-2008-02-142737  0.577
2007 Goldberg GL, Alpdogan O, Muriglan SJ, Hammett MV, Milton MK, Eng JM, Hubbard VM, Kochman A, Willis LM, Greenberg AS, Tjoe KH, Sutherland JS, Chidgey A, van den Brink MR, Boyd RL. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. Journal of Immunology (Baltimore, Md. : 1950). 178: 7473-84. PMID 17513799 DOI: 10.4049/Jimmunol.178.11.7473  0.614
2007 Lu SX, Willis L, Smith M, Suh D, King C, Bautista J, Chow M, Cabrera-Perez J, Hubbard V, Rotolo J, Liu C, Murphy G, Alpdogan O, Blumberg R, Holmes K, et al. CEACAM-1 Is Involved in Graft-Versus-Host-Disease in Murine Allogeneic Bone Marrow Transplantation Models. Blood. 110: 67-67. DOI: 10.1182/Blood.V110.11.67.67  0.578
2007 Lu SX, Alpdogan O, Campos R, Wang X, Gao G, Chow M, Lin J, Suh D, King C, Hubbard VM, Bautista JL, Kochman AA, Zakrzewski JL, Smith OM, Grubin J, et al. Discovery and Validation of STAT-3 and ERK1/2 Phosphorylation as Critical for the Function of Alloactivated T Cells in Acute Graft-Versus-Host-Disease Via a Novel Technique for Drug Discovery. Blood. 110: 3236-3236. DOI: 10.1182/Blood.V110.11.3236.3236  0.563
2007 Brink MRMvd, Willis L, Bautista J, Chow M, Smith OM, Cabrera-Perez J, Suh D, King C, Zakrzewski J, Kochman A, Hubbard V, Turbide C, Beauchemin N, Lu SX. 330: Carcinoembryonic antigen related cell adhesion molecule 1 is an important suppressor of intestinal and systemic acute graft-versus-host-disease Biology of Blood and Marrow Transplantation. 13: 120. DOI: 10.1016/J.Bbmt.2006.12.335  0.442
2006 Perales MA, Diab A, Cohen AD, Huggins DW, Guevara-Patiño JA, Hubbard VM, Engelhorn ME, Kochman AA, Eng JM, Mortazavi F, Alpdogan O, Terwey TH, Heller G, Wolchok JD, Houghton AN, et al. DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation. Journal of Immunology (Baltimore, Md. : 1950). 177: 4159-67. PMID 16951381 DOI: 10.4049/Jimmunol.177.6.4159  0.507
2006 Zakrzewski JL, Kochman AA, Lu SX, Terwey TH, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Smith OM, Grubin J, Patel N, Chow A, Cabrera-Perez J, Radhakrishnan R, Diab A, et al. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nature Medicine. 12: 1039-47. PMID 16936725 DOI: 10.1038/Nm1463  0.625
2006 Mayer-Kuckuk P, Doubrovin M, Bidaut L, Budak-Alpdogan T, Cai S, Hubbard V, Alpdogan O, van den Brink M, Bertino JR, Blasberg RG, Banerjee D, Gelovani J. Molecular imaging reveals skeletal engraftment sites of transplanted bone marrow cells. Cell Transplantation. 15: 75-82. PMID 16700332 DOI: 10.3727/000000006783982278  0.412
2006 Alpdogan O, Hubbard VM, Smith OM, Patel N, Lu S, Goldberg GL, Gray DH, Feinman J, Kochman AA, Eng JM, Suh D, Muriglan SJ, Boyd RL, van den Brink MR. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood. 107: 2453-60. PMID 16304055 DOI: 10.1182/Blood-2005-07-2831  0.53
2006 Waldman E, Lu SX, Hubbard VM, Kochman AA, Eng JM, Terwey TH, Muriglan SJ, Kim TD, Heller G, Murphy GF, Liu C, Alpdogan O, van den Brink MR. Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine. Blood. 107: 1703-11. PMID 16291587 DOI: 10.1182/Blood-2005-08-3445  0.577
2006 Kappel BJ, Pinilla-Ibarz J, Kochman AA, Eng JM, Hubbard VM, Leiner I, Pamer EG, Heller G, van den Brink MR, Scheinberg DA. Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model. Blood. 107: 2045-51. PMID 16269613 DOI: 10.1182/Blood-2005-07-2828  0.602
2006 Alpdogan O, Patel N, Suh D, Grubin J, McGoldrick S, Smith OM, Lu S, King C, Kochman A, Hubbard V, Brink MRMvd. Peripheral T Cell Apoptosis Is Associated with Homeostatic T Cell Proliferation and Plays a Significant Role in Post-Transplant Immune Deficiency. Blood. 108: 71-71. DOI: 10.1182/Blood.V108.11.71.71  0.582
2006 Zakrzewski JL, Kochman AA, Lu SX, Terwey T, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Cabrera-Perez J, Heller G, Zuniga-Pflucker J-, Alpdogan O, Brink MRMvd. Adoptive transfer of in vitro generated T cell precursors improves T cell reconstitution and mediates graft-versus-tumor activity without graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients Biology of Blood and Marrow Transplantation. 12: 82. DOI: 10.1016/J.Bbmt.2005.11.255  0.621
2006 Lu SX, Chow MY, Hubbard VM, Suh DY, Kim TD, Kochman A, Zakrzewski J, Cabrera-Perez J, Alpdogan O, Brink MRMvd. T-cell signaling in allogeneic bone marrow transplantation Biology of Blood and Marrow Transplantation. 12: 24. DOI: 10.1016/J.Bbmt.2005.11.075  0.521
2005 Terwey TH, Kim TD, Kochman AA, Hubbard VM, Lu S, Zakrzewski JL, Ramirez-Montagut T, Eng JM, Muriglan SJ, Heller G, Murphy GF, Liu C, Budak-Alpdogan T, Alpdogan O, van den Brink MR. CCR2 is required for CD8-induced graft-versus-host disease. Blood. 106: 3322-30. PMID 16037386 DOI: 10.1182/Blood-2005-05-1860  0.594
2005 Hubbard VM, Eng JM, Ramirez-Montagut T, Tjoe KH, Muriglan SJ, Kochman AA, Terwey TH, Willis LM, Schiro R, Heller G, Murphy GF, Liu C, Alpdogan O, van den Brink MR. Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation. Blood. 106: 3285-92. PMID 15956289 DOI: 10.1182/Blood-2005-01-0410  0.606
2005 Alpdogan O, Eng JM, Muriglan SJ, Willis LM, Hubbard VM, Tjoe KH, Terwey TH, Kochman A, van den Brink MR. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood. 105: 865-73. PMID 15280205 DOI: 10.1182/Blood-2003-09-3344  0.538
2005 Waghmare AA, Hubbard V, Brink Mvd. 293 Toll Like Receptors In Allogeneic Hematopoietic Stem Cell Transplantation Journal of Investigative Medicine. 53. DOI: 10.2310/6650.2005.00005.292  0.51
2005 Zakrzewski JL, Kochman AA, Lu SX, Terwey TH, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Cabrera-Perez J, Radhakrishnan R, Heller G, Zuniga-Pflucker JC, Alpdogan O, Brink MRMvd. Adoptive Transfer of In Vitro Generated T Cell Precursors Enhances Donor T Cell Reconstitution and Graft-Versus-Tumor Activity in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Blood. 106: 63-63. DOI: 10.1182/Blood.V106.11.63.63  0.616
2005 Ramirez-Montagut T, Chow A, Kochman AA, Hubbard VM, Suh D, Smith OM, Sindhi H, Terwey TH, Kim TD, Waldman E, Alpdogan O, van den Brink MR. Graft-Versus-Tumor Activity Against Renal Cell Carcinoma in a Mouse Model of HSCT. Blood. 106: 1317-1317. DOI: 10.1182/Blood.V106.11.1317.1317  0.58
2005 Kappel BJ, Pinilla-Ibarz J, Kochman AA, Eng JM, Hubbard VM, Leiner IM, Pamer EG, van den Brink MR, Scheinberg DA. Remodeling Specific Immunity by Use of MHC-Tetramers Distinguishes Graft-Versus-Tumor Activity from Graft-Versus-Host-Disease. Blood. 106: 1300-1300. DOI: 10.1182/Blood.V106.11.1300.1300  0.618
2005 Lu SX, Hubbard VM, Chow MY, Kim TD, Suh DY, Kochman A, Zakrzewski J, Cabrera-Perez J, Alpdogan O, Brink MMRMvd. Signaling Profiles of T Cells during Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 106: 1262-1262. DOI: 10.1182/Blood.V106.11.1262.1262  0.516
2005 Terwey TH, Kochman AA, Eng JM, Hubbard VM, Muriglan SJ, Waldman ED, Zakrzewski JL, Alpdogan O, Brink MRMvd. CC chemokine receptor 2 is involved in intestinal homing of alloreactive donor CD8+ T cells during GVHD Biology of Blood and Marrow Transplantation. 11: 49. DOI: 10.1016/J.Bbmt.2004.12.144  0.487
2005 Keating AR, McGoldrick S, Kochman A, Eng JM, Hubbard VM, Brink MRMvd. Peri-transplant imatinib administration results in significant mortality of recipients of allogeneic hematopoietic stem cell transplants due to impaired bone marrow recovery Biology of Blood and Marrow Transplantation. 11: 37-38. DOI: 10.1016/J.Bbmt.2004.12.109  0.453
2004 Muriglan SJ, Ramirez-Montagut T, Alpdogan O, Van Huystee TW, Eng JM, Hubbard VM, Kochman AA, Tjoe KH, Riccardi C, Pandolfi PP, Sakaguchi S, Houghton AN, Van Den Brink MR. GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease. The Journal of Experimental Medicine. 200: 149-57. PMID 15249593 DOI: 10.1084/Jem.20040116  0.485
2004 Hubbard VM, Eng JM, Tjoe KH, Ramirez-Montagut T, Muriglan SJ, Kochman AA, Terwey TH, Schiro R, Alpdogan O, Brink MRMvd. Absence of Inducible Costimulator (ICOS) on Alloreactive T Cells Reduces Graft-versus-Host-Disease While Leaving Graft-Versus-Tumor Activity Intact. Blood. 104: 592-592. DOI: 10.1182/Blood.V104.11.592.592  0.62
2004 Goldberg GL, Alpdogan O, Muriglan SJ, Hammett M, Milton MK, Eng JM, Hubbard VM, Kochman A, Willis LM, Greenberg AS, Tjoe KH, Sutherland JS, Chidgey A, Boyd RL, Brink MRMvd. Lymphocyte Function and Molecular Mechanisms of Enhanced Immune Reconstitution Following Sex Steroid Ablation and Hemopoietic Stem Cell Transplantation (HSCT). Blood. 104: 4990-4990. DOI: 10.1182/Blood.V104.11.4990.4990  0.547
2004 Diab A, Hubbard VM, Cohen A, Huggins D, Kochman A, Guevarra JA, Engelhorn M, Wolchok JD, van den Brink M, Houghton AN, Perales M. DNA Immunization Against Melanoma Antigens Enhances Tumor Immunity in Mice Following Sub-Lethal Irradiation and Immune Reconstitution. Blood. 104: 3057-3057. DOI: 10.1182/Blood.V104.11.3057.3057  0.39
2004 Diab A, Perales M, Cohen A, Hubbard VM, Eng J, Huggins D, Engelhorn M, Guevarra JA, Alpdogan O, Wolchok JD, Kochman A, Houghton AN, Brink Mvd. DNA Immunization Against Melanoma Antigens Enhances Tumor Immunity in Mouse Models of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). Blood. 104: 304-304. DOI: 10.1182/Blood.V104.11.304.304  0.467
2004 Tjoe KH, Eng JM, Alpdogan O, Muriglan SJ, Hubbard VM, Kochman AA, Schiro R, Brink MRMvd. Absence of inducible costimulator on alloreactive T cells reduces graft-versus-host-disease while leaving graft-versus-tumor activity intact Biology of Blood and Marrow Transplantation. 10: 50-51. DOI: 10.1016/J.Bbmt.2003.12.252  0.573
2004 Waldman ED, Alpdogan O, Petrovic A, Eng JM, Hubbard V, Kochman A, Muriglan S, Brink MRMvd. β7−/− donor T cells cause less graft-versus-host disease while preserving graft-versus-tumor activity Biology of Blood and Marrow Transplantation. 10: 48-49. DOI: 10.1016/J.Bbmt.2003.12.236  0.569
2004 Muriglan SJ, Ramirez-Montagut T, Alpdogan O, Huystee Tv, Eng JM, Hubbard VM, Kochman AA, Tjoe KH, Brink MRMvD. The paradoxical effect of glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) activation on alloreactive CD4 and CD8 T cells and the development of GVHD Biology of Blood and Marrow Transplantation. 10: 5. DOI: 10.1016/J.Bbmt.2003.12.009  0.404
2004 Alpdogan O, McGoldrick S, Budak-Alpdogan T, Hubbard VM, Eng JM, Muriglan SJ, Kochman A, Brink MRMvd. Immune reconstitution after allogeneic bone marrow transplantation involves peripheral T cell apoptosis Biology of Blood and Marrow Transplantation. 10: 58-59. DOI: 10.1016/J.Bbmt.2003.12.007  0.546
Show low-probability matches.